“antibiotic” Archives

in
Entry Author Date Location
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3 08/10/20 Boston
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink 12/11/19 National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Paratek Wins Two FDA Drug Approvals for Three Conditions in Same Day 10/03/18 Boston
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Macrolide Pharma Raises $20M, Names Former Intarcia Exec Karande CEO 04/02/18 Boston
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
FDA Nixes Aradigm’s Inhaled Antibiotic, Asks for New Clinical Trial 01/29/18 San Francisco
Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics 03/08/17 Boston
Bayer Enlists Trana Discovery to Find New Fungicides for Field Crops 02/08/17 Raleigh Durham
FDA Rejects Cempra Antibiotic, Asks for Another Clinical Trial 12/29/16 Raleigh Durham
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
AstraZeneca Spinout Entasis Snags $50M For Anti-Infective Treatments 04/04/16 Boston
With New Data, Highs and Lows For Akebia, Flexion, Tetraphase 09/08/15 Boston
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Third Rock’s New Revolution Looks to Squeeze More Drugs From Nature 02/04/15 San Francisco
Roundup: New Funds at Wisegate, Savara, Besomebody, & Dallas startups 06/17/14 Texas
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More 05/17/13 San Diego
Brain Cells’ Antidepressant Disappoints in Clinical Study, Otonomy Hears the Sound of Money, Cognionics Wins Startup Competition, & More San Diego Life Sciences News 06/17/10 San Diego
Sirtris Founders Resurface with New Fund, Icahn Continues to Make Biotech Waves, Sentillion Bought by Microsoft, & More Boston-Area Life Sciences News 02/19/10 Boston
Teva Takes Aim at Cubist Pharma’s Key Antibiotic Business 02/10/09 Boston
Targanta Faces New Challenges to Raise Cash After FDA Shoots Down the Firm’s Antibiotic 12/10/08 Boston
Page 1 of 1